Induction of an epitope-specific humoral immune response by lipopeptide-hapten conjugates: Enhancement of the anti-melittin response by a synthetic T helper (T-h)-cell epitope

被引:16
作者
Hoffmann, P
Loleit, M
Mittenbuhler, K
Beck, W
Wiesmuller, KH
Jung, G
Bessler, WG
机构
[1] UNIV TUBINGEN,INST ORGAN CHEM,D-72076 TUBINGEN,GERMANY
[2] UNIV TUBINGEN,NMI,D-72762 REUTLINGEN,GERMANY
来源
FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY | 1997年 / 17卷 / 04期
关键词
synthetic vaccines; lipopeptide adjuvants; adjuvant T helper-cell epitopes; vaccine design; immune stimulation;
D O I
10.1111/j.1574-695X.1997.tb01016.x
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Lipopeptides of bacterial origin constitute potent immunoadjuvants when combined with antigens. After the immunization with lipopeptides covalently coupled to non-immunogenic low-molecular-mass antigens or haptens, a hapten-specific humoral immune response can often be obtained. The response against synthetically prepared melittin fragments was further enhanced by the additional introduction of a T helper (T-h)-cell epitope into the lipopeptide-hapten conjugate. The T-h-cell epitope applied, which is presented by the MHC class II molecule of the BALB/c (H-2(d)) haplotype, consisted of a synthetic 16-amino-acid oligopeptide derived from sperm whale myoglobin. The immune-enhancing effect was most pronounced for the melittin-derived peptide fragments [Mel(1-16)] and [Mel(17-26)-CONH2], Antibodies obtained after 3 immunizations with the conjugates recognized the synthetic as well as the native melittin molecule. Our results show that it is possible to markedly enhance a weak hapten-specific immune response by coupling the haptens to a lipopeptide conjugated to a haplotype-specific T helper-cell epitope. The novel conjugates are well suited for the optimization of immunization procedures, and for the development of novel synthetic vaccines.
引用
收藏
页码:225 / 234
页数:10
相关论文
共 26 条
  • [1] ALBERICIO F, 1987, INT J PEPT PROT RES, V30, P206
  • [2] SYNTHETIC LIPOPEPTIDES AS NOVEL ADJUVANTS
    BESSLER, WG
    JUNG, G
    [J]. RESEARCH IN IMMUNOLOGY, 1992, 143 (05): : 548 - 553
  • [3] BESSLER WG, 1990, IMMUNOTHERAPEUTIC PR, P37
  • [4] SITE RECOGNITION BY PROTEIN-PRIMED T-CELLS SHOWS A NONSPECIFIC PEPTIDE SIZE REQUIREMENT BEYOND THE ESSENTIAL RESIDUES OF THE SITE - DEMONSTRATION BY DEFINING AN IMMUNODOMINANT T-SITE IN MYOGLOBIN
    BIXLER, GS
    BEAN, M
    ATASSI, MZ
    [J]. BIOCHEMICAL JOURNAL, 1986, 240 (01) : 139 - 146
  • [5] BOLTZ T, 1988, LYMPHOCYTE ACTIVATIO, P379
  • [6] INVIVO PRIMING OF VIRUS-SPECIFIC CYTO-TOXIC LYMPHOCYTES-T WITH SYNTHETIC LIPOPEPTIDE VACCINE
    DERES, K
    SCHILD, H
    WIESMULLER, KH
    JUNG, G
    RAMMENSEE, HG
    [J]. NATURE, 1989, 342 (6249) : 561 - 564
  • [7] FEHLNER PF, 1991, J IMMUNOL, V146, P2664
  • [8] Hoffmann P, 1990, Hum Antibodies Hybridomas, V1, P137
  • [9] MULTIPLE PEPTIDE-SYNTHESIS METHODS AND THEIR APPLICATIONS
    JUNG, G
    BECKSICKINGER, AG
    [J]. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 1992, 31 (04) : 367 - 383
  • [10] KING DS, 1990, INT J PEPT PROT RES, V36, P255